MACROGENICS INC financial data

Symbol
MGNX on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 430% % 18%
Quick Ratio 14% % 374%
Debt-to-equity 225% % 70%
Return On Equity -98% % -9.9%
Return On Assets -30% % 21%
Operating Margin -89% % -17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63,258,532 shares 0.79%
Common Stock, Shares, Outstanding 63,258,532 shares 0.79%
Entity Public Float $259,400,000 USD
Common Stock, Value, Issued $633,000 USD 0.96%
Weighted Average Number of Shares Outstanding, Basic 63,233,266 shares 0.78%
Weighted Average Number of Shares Outstanding, Diluted 63,283,624 shares 0.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $127,625,000 USD -9.7%
Research and Development Expense $152,088,000 USD -18%
General and Administrative Expense $57,736,000 USD 3.5%
Costs and Expenses $241,209,000 USD -2.9%
Operating Income (Loss) $113,584,000 USD -6.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,822,000 USD -70%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $75,886,000 USD 22%
Earnings Per Share, Basic -1 USD/shares 25%
Earnings Per Share, Diluted -1 USD/shares 24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $80,129,000 USD -55%
Accounts Receivable, after Allowance for Credit Loss, Current $69,230,000 USD 691%
Inventory, Net $8,750,000 USD 170%
Assets, Current $232,091,000 USD 4.5%
Property, Plant and Equipment, Net $13,975,000 USD -27%
Operating Lease, Right-of-Use Asset $23,305,000 USD 5.9%
Other Assets, Noncurrent $1,392,000 USD 17%
Assets $270,763,000 USD 2.4%
Accounts Payable, Current $5,940,000 USD -10%
Accrued Liabilities, Current $23,087,000 USD -6.3%
Contract with Customer, Liability, Current $10,302,000 USD -56%
Liabilities, Current $44,470,000 USD -25%
Contract with Customer, Liability, Noncurrent $55,840,000 USD 0.61%
Operating Lease, Liability, Noncurrent $31,868,000 USD 8.6%
Other Liabilities, Noncurrent $1,328,000 USD 415%
Liabilities $203,762,000 USD 41%
Retained Earnings (Accumulated Deficit) $1,230,183,000 USD -6.6%
Stockholders' Equity Attributable to Parent $67,001,000 USD -44%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $67,001,000 USD -44%
Liabilities and Equity $270,763,000 USD 2.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $46,890,000 USD -2.7%
Net Cash Provided by (Used in) Financing Activities $282,000 USD -214%
Net Cash Provided by (Used in) Investing Activities $9,902,000 USD -60%
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $37,270,000 USD -81%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $80,129,000 USD -55%
Deferred Tax Assets, Valuation Allowance $401,297,000 USD 9.9%
Deferred Tax Assets, Gross $410,197,000 USD 9.9%
Operating Lease, Liability $37,461,000 USD 10%
Payments to Acquire Property, Plant, and Equipment $529,000 USD -64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $75,895,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid $70,482,000 USD 0.29%
Property, Plant and Equipment, Gross $106,787,000 USD -3.1%
Operating Lease, Liability, Current $5,141,000 USD 8.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,507,000 USD 8.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,185,000 USD 29%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33,021,000 USD -9%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,258,000 USD 49%
Unrecognized Tax Benefits $9,334,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $7,413,000 USD 50%
Depreciation, Depletion and Amortization $1,771,000 USD -3.8%
Deferred Tax Assets, Net of Valuation Allowance $8,900,000 USD 5.9%
Share-based Payment Arrangement, Expense $22,889,000 USD 1.6%
Interest Expense $4,211,000 USD 270%